Published in Blood on November 18, 2014
Danazol Treatment for Telomere Diseases. N Engl J Med (2016) 3.39
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia. Cancer Genet (2015) 1.31
Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma (2015) 0.98
The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol (2015) 0.91
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med (2017) 0.82
Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood. Front Pediatr (2015) 0.82
Hematopoietic stem cell transplantation for acquired aplastic anemia. Curr Opin Hematol (2016) 0.78
Anemia of Central Origin. Semin Hematol (2015) 0.76
Short telomere length and its correlation with gene mutations in myelodysplastic syndrome. J Hematol Oncol (2016) 0.75
Clonal evolution in leukemia. Nat Med (2017) 0.75
Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med (2011) 9.90
The origin and evolution of mutations in acute myeloid leukemia. Cell (2012) 9.66
Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med (2005) 7.09
Telomeres and telomerase in cancer. Carcinogenesis (2009) 4.28
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia (2013) 3.93
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA (2003) 3.90
Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet (2003) 3.77
Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer (2008) 2.54
How I treat acquired aplastic anemia. Blood (2012) 2.44
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood (2009) 2.12
The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood (1992) 1.99
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell (2014) 1.98
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome. Blood (2014) 1.82
Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol (2005) 1.69
Late clonal diseases of treated aplastic anemia. Semin Hematol (2000) 1.27
Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia. Leukemia (2011) 1.21
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia. Leukemia (2013) 1.14
Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia (2014) 0.91
Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica (2014) 0.87